GSK Merges Anti-Smoking, Anti-Obesity Units

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK GlaxoSmithKline Consumer Healthcare is consolidating its anti-smoking and anti-obesity brands under a single marketing unit in Parsippany, N.J. — a move that will trigger layoffs. The new division will be headed by a new marketing chief, vp for behavioral sciences Karen Scollick.

Scollick was previously general manager of GSK Consumer Healthcare in Canada. She replaces Steve Burton on the Alli diet drug brand, who left his position in June. On the smoking brands — including NicoDerm CQ, Nicorette and Commit — she replaces Bill Slivka, who is transitioning to a more strategic role, said GSK rep Malesia Dunn.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in